With several of the firm's personnel formerly with a major pharmaeutical firm (GSK) that was consolidating its operation in the State of Montana, in close collaboration with the University of Montana, Inimmune was formed, The firm is organized around harnessing the human immune system to create next generation of new immunomodulatory therapeutics for the treatment or prevention of allergy, autoimmunity, upper respiratoty tract infections and cancer, by targeting innate immune receptors. Members of the assembled team collectively have decades of relevant expertise discovering and developing safe and effective immunomodulators that can be used for the treatment of a wide array of diseases and disorders.
